Italian scientists from the University of Modena and Holostem Terapie Avanzate have developed the first advanced therapy medicinal product containing stem cells, called Holoclar. The Holoclar therapy can restore sight following corneal burns and stromal damage by harvesting the patient’s own stem cells from the limbus, culturing the stem cells into a sheet of healthy corneal tissue, and then transplanting the cornea back onto the patient’s eye.
Stem cells can be cultured outside of the body, so Holoclar only requires a small area of the eye to be biopsied. This eliminates the need for invasive surgery and reduces the risk of damage to the rest of the eye. According to Dr. Michele De Luca, principle investigator and co-founder of Holostem, “The authorization process has been long and complex, but the result achieved today shows that cells can be cultured according to pharmaceutical standards appropriate to guarantee safety and efficacy.”
Dr. De Luca’s research is an example of how scientists are gaining insights that will facilitate more effective stem cell treatments leading to better outcomes. To learn more about the value of preserving your own mesenchymal stem cells for use in future therapies and how to bank your own stem cells through a non-evasive and affordable method by recovering your dental pulp stem cells, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™.